Discovery of novel KRAS G12C inhibitor with promising in vivo efficacy and safety
Sep. 21, 2022
Researchers from Sun Yat-sen University, Southern Medical University and Gannan Medical University reported the discovery of novel quinazoline-based KRAS G12C inhibitors as potential anticancer agents.